Metraipolis › archive › dc_525ce623a2d7
Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II… — Europe PMC PMID:41299684
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41299684
- DOI
- 10.1186/s13045-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T05:44:52.661Z
- SHA-256 of the archived text
3527c6bec6d45c4d51fc55732a8b753ee09d77e0f8451427761797ead4a1b766- Stable URL of this page
https://metraipolis.com/documento/dc_525ce623a2d7
How to cite
Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II… — Europe PMC PMID:41299684 — Europe PMC (en), https://europepmc.org/article/MED/41299684 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_525ce623a2d7 (Metraipolis archive dc_525ce623a2d7, sha256 3527c6bec6d45c4d51fc55732a8b753ee09d77e0f8451427761797ead4a1b766)
BibTeX
@misc{dc525ce623a2d7,
title = {Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II… — Europe PMC PMID:41299684},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41299684},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_525ce623a2d7; sha256 3527c6bec6d45c4d51fc55732a8b753ee09d77e0f8451427761797ead4a1b766},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41299684. Agents can read the archived copy with the MCP tool read_document.